4 курс / Акушерство и гинекология / Лекарственные_средства,_применяемые_в_акушерстве_и_гинекологии,
.pdf
Ɂɚɛɨɥɟɜɚɧɢɟ, |
|
Ʌɟɤɚɪɫɬɜɟɧɧɵɟ |
Ɋɚɡɨɜɚɹ |
ɋɭɬɨɱɧɚɹ |
ɋɩɨɫɨɛ |
Ⱦɥɢɬɟɥɶɧɨɫɬɶ |
ɉɪɢɦɟɱɚɧɢɟ |
ɨɫɧɨɜɧɨɣ |
|
ɩɪɟɩɚɪɚɬɵ (Ʌɋ) |
ɞɨɡɚ |
ɞɨɡɚ |
ɜɜɟɞɟɧɢɹ |
ɬɟɪɚɩɢɢ |
|
ɜɨɡɛɭɞɢɬɟɥɶ |
|
|
|
|
|
|
|
|
|
ɥɢɧ») |
|
|
|
|
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
Ⱥɦɨɤɫɢɰɢɥɢɧ+ɤɥɚɜɭɥɚ- |
1,2 ɝ |
3,6–4,8 ɝ |
ɜ/ɜ |
5 ɫɭɬ |
|
|
|
ɧɨɜɚɹ ɤɢɫɥɨɬɚ («Ⱥɭɝ- |
|
|
|
|
|
|
|
ɦɟɧɬɢɧ», «Ⱥɦɨɤɫɢɤ- |
|
|
|
|
|
|
|
ɥɚɜ») |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
+ |
ɩɨɫɥɟ ɨɤɨɧɱɚɧɢɹ ɤɭɪɫɚ |
|
|
|
|
|
|
|
Ⱥɦɩɢɰɢɥɥɢɧ |
0,5 ɝ |
1,5–2 ɝ |
ɜɧɭɬɪɶ |
5–10 ɫɭɬ |
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
Ⱥɦɨɤɫɢɰɢɥɥɢɧ |
0,25–0,5 ɝ |
0,75–1,5 ɝ |
ɜɧɭɬɪɶ |
5–10 ɫɭɬ |
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
Ⱥɦɩɢɰɢɥ- |
0,375–0,75 ɝ |
0,75–1,5 ɝ |
ɜɧɭɬɪɶ |
5–10 ɫɭɬ |
|
|
|
ɥɢɧ+ɫɭɥɶɛɚɤɬɚɦ |
|
|
|
|
|
|
|
(«ɍɧɚɡɢɧ», «ɋɭɥɚɰɢɥ- |
|
|
|
|
|
|
|
ɥɢɧ») |
|
|
|
|
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
Ⱥɦɨɤɫɢɰɢ- |
0,375–0,625 ɝ |
0,75–1,25 ɝ |
ɜɧɭɬɪɶ |
5–10 ɫɭɬ |
|
|
|
ɥɢɧ+ɤɥɚɜɭɥɚɧɨɜɚɹ ɤɢ- |
|
|
|
|
|
|
|
ɫɥɨɬɚ («Ⱥɭɝɦɟɧɬɢɧ», |
|
|
|
|
|
|
|
«Ⱥɦɨɤɫɢɤɥɚɜ») |
|
|
|
|
ɇɚ ɩɟɪɢɨɞ ɚɧɬɢɛɚɤɬɟ- |
|
|
|
|
|
|
|
|
|
ɢɥɢ |
|
|
|
|
||
|
|
|
|
|
|
|
ɪɢɚɥɶɧɨɣ ɬɟɪɚɩɢɢ ɰɟ- |
|
|
ɐɟɮɭɪɨɤɫɢɦ («Ɂɢɧɚ- |
0,75 ɝ |
2,25–4,5 ɝ |
ɜ/ɜ, ɜ/ɦ |
5 ɫɭɬ |
|
|
|
ɰɟɮ») |
|
|
|
|
ɮɚɥɨɫɩɨɪɢɧɚɦɢ ɢ |
|
|
ɢɥɢ |
|
|
|
|
ɮɬɨɪɯɢɧɨɥɨɧɚɦɢ ɧɟ- |
|
|
ɐɟɮɨɬɚɤɫɢɦ («Ʉɥɚɮɨ- |
1–2 ɝ |
3–6 ɝ |
ɜ/ɜ, ɜ/ɦ |
5 ɫɭɬ |
ɨɛɯɨɞɢɦɨ ɜɪɟɦɟɧɧɨ |
|
|
ɪɚɧ») |
|
|
|
|
ɩɪɟɤɪɚɬɢɬɶ ɝɪɭɞɧɨɟ |
|
|
|
|
|
|
|
|
142
6 Раздел
Ɂɚɛɨɥɟɜɚɧɢɟ, |
|
Ʌɟɤɚɪɫɬɜɟɧɧɵɟ |
Ɋɚɡɨɜɚɹ |
ɋɭɬɨɱɧɚɹ |
ɋɩɨɫɨɛ |
|
Ⱦɥɢɬɟɥɶɧɨɫɬɶ |
ɉɪɢɦɟɱɚɧɢɟ |
ɨɫɧɨɜɧɨɣ |
|
ɩɪɟɩɚɪɚɬɵ (Ʌɋ) |
ɞɨɡɚ |
ɞɨɡɚ |
ɜɜɟɞɟɧɢɹ |
|
ɬɟɪɚɩɢɢ |
|
ɜɨɡɛɭɞɢɬɟɥɶ |
|
|
|
|
|
|
|
|
|
|
ɢɥɢ |
|
|
|
|
|
ɜɫɤɚɪɦɥɢɜɚɧɢɟ |
|
|
ɐɟɮɬɚɡɢɞɢɦ («Ɏɨɪɬɭɦ») |
1 ɝ |
3–6 ɝ |
ɜ/ɜ, ɜ/ɦ |
5 |
ɫɭɬ |
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
|
ɐɟɮɨɩɟɪɚɡɨɧ («ɐɟɮɨ- |
1–2 ɝ |
4–8 ɝ |
ɜ/ɜ, ɜ/ɦ |
5 |
ɫɭɬ |
|
|
|
ɛɢɞ») |
|
|
|
|
|
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
|
ɐɟɮɬɪɢɚɤɫɨɧ («Ɋɨɰɟ- |
0,5–1 ɝ |
1–2 ɝ |
ɜ/ɜ, ɜ/ɦ |
5 |
ɫɭɬ |
|
|
|
ɮɢɧ», «ɐɟɮɬɪɢɚɛɨɥ») |
|
|
|
|
|
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
|
ɂɦɢɩɟɧɟɦ+ɰɢɥɚɫɬɚɬɢɧ |
0,5–1 ɝ |
2–3 ɝ |
ɜ/ɜ |
5–7 ɫɭɬ |
|
|
|
|
(«Ɍɢɟɧɚɦ») |
|
|
|
|
|
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
|
Ɇɟɪɨɩɟɧɟɦ («Ɇɟɪɨ- |
0,5–1 ɝ |
2–3 ɝ |
ɜ/ɜ |
5–7 ɫɭɬ |
|
|
|
|
ɧɟɦ») |
|
|
|
|
|
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
|
Ɉɮɥɨɤɫɚɰɢɧ («Ɍɚɪɢ- |
0,1–2 ɝ |
0,2–4 ɝ |
ɜ/ɜ |
5 |
ɫɭɬ |
|
|
|
ɜɢɞ») |
|
|
|
|
|
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
|
ɉɟɮɥɨɤɫɚɰɢɧ («Ⱥɛɚɤ- |
0,2–0,4 ɝ |
0,4–0,8 ɝ |
ɜ/ɜ |
5 |
ɫɭɬ |
|
|
|
ɬɚɥ») |
|
|
|
|
|
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
|
Ʌɨɦɟɮɥɨɤɫɚɰɢɧ («Ɇɚɤ- |
0,4 ɝ |
0,4–0,8 ɝ |
ɜ/ɜ |
5 |
ɫɭɬ |
|
|
|
ɫɚɤɜɢɧ») |
|
|
|
|
|
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
|
ɐɢɩɪɨɮɥɨɤɫɚɰɢɧ |
0,25–0,5 ɝ |
0,5–0,75 ɝ |
ɜ/ɜ |
5 |
ɫɭɬ |
|
|
|
(«Ʉɜɢɧɬɨɪ», «ɐɢɩɪɨ- |
|
|
|
|
|
|
143 ...заболеваний инфекционных терапии при применяемые ЛС,
Ɂɚɛɨɥɟɜɚɧɢɟ, |
|
|
Ʌɟɤɚɪɫɬɜɟɧɧɵɟ |
Ɋɚɡɨɜɚɹ |
ɋɭɬɨɱɧɚɹ |
ɋɩɨɫɨɛ |
Ⱦɥɢɬɟɥɶɧɨɫɬɶ |
ɉɪɢɦɟɱɚɧɢɟ |
ɨɫɧɨɜɧɨɣ |
|
|
ɩɪɟɩɚɪɚɬɵ (Ʌɋ) |
ɞɨɡɚ |
ɞɨɡɚ |
ɜɜɟɞɟɧɢɹ |
ɬɟɪɚɩɢɢ |
|
ɜɨɡɛɭɞɢɬɟɥɶ |
|
|
|
|
|
|
|
|
|
|
ɛɚɣ») |
|
|
|
|
|
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
|
Ʌɟɜɨɮɥɨɤɫɚɰɢɧ («Ɍɚɜɚ- |
0,25–0,5 ɝ |
0,5–1,0 |
ɜ/ɜ |
5 ɫɭɬ |
|
|
|
|
ɧɢɤ») |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
+ |
ɩɨɫɥɟ ɨɤɨɧɱɚɧɢɹ ɤɭɪɫɚ |
|
|
|
|
|
|
|
|
|
Ʌɟɜɨɮɥɨɤɫɚɰɢɧ («Ɍɚ- |
0,25–0,5 ɝ |
0,25–0,5 ɝ |
ɜɧɭɬɪɶ |
5 ɫɭɬ |
|
|
|
|
ɜɚɧɢɤ») |
|
|
|
|
|
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
|
Ɉɮɥɨɤɫɚɰɢɧ («Ɍɚɪɢ- |
0,1–0,2 ɝ |
0,2–0,4 ɝ |
ɜɧɭɬɪɶ |
5 ɫɭɬ |
|
|
|
|
ɜɢɞ») |
|
|
|
|
|
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
|
ɉɟɮɥɨɤɫɚɰɢɧ («Ⱥɛɚɤ- |
0,2–0,4 ɝ |
0,4 ɝ |
ɜɧɭɬɪɶ |
5 ɫɭɬ |
|
|
|
|
ɬɚɥ») |
|
|
|
|
|
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
|
ɐɢɩɪɨɮɥɨɤɫɚɰɢɧ |
0,25–0,5 ɝ |
0,5 ɝ |
ɜɧɭɬɪɶ |
5 ɫɭɬ |
|
|
|
|
(«Ʉɜɢɧɬɨɪ», «ɐɢɩɪɨ- |
|
|
|
|
|
|
|
|
ɛɚɣ») |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
|
|
|
ɉɟɪɨɪɚɥɶɧɵɟ ɮɨɪɦɵ ɧɟɮɬɨɪɢɪɨɜɚɧɧɵɯ ɯɢɧɨɥɨɧɨɜ ɢ ɧɢɬɪɨɮɭɪɚɧɨɜ ɦɨɝɭɬ ɩɪɢɦɟɧɹɬɶɫɹ ɜ |
|
||||
|
|
|
ɤɚɱɟɫɬɜɟ ɦɨɧɨɬɟɪɚɩɢɢ: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
ɇɚɥɢɞɢɤɫɨɜɚɹ ɤɢɫɥɨɬɚ |
0,5 ɝ |
2 ɝ |
ɜɧɭɬɪɶ |
10–12 ɫɭɬ |
|
|
|
|
(«ɇɟɜɢɝɪɚɦɨɧ») |
|
|
|
|
|
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
|
Ɉɤɫɨɥɢɧɨɜɚɹ ɤɢɫɥɨɬɚ |
0,5–1 ɝ |
1,5–2 ɝ |
ɜɧɭɬɪɶ |
10–12 ɫɭɬ |
|
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
|
ɉɢɩɟɦɢɞɨɜɚɹ ɤɢɫɥɨɬɚ |
0,4 ɝ |
0,8 ɝ |
ɜɧɭɬɪɶ |
10–12 ɫɭɬ |
|
|
|
|
|
|
|
|
|
|
144
6 Раздел
Ɂɚɛɨɥɟɜɚɧɢɟ, |
|
Ʌɟɤɚɪɫɬɜɟɧɧɵɟ |
Ɋɚɡɨɜɚɹ |
|
ɋɭɬɨɱɧɚɹ |
ɋɩɨɫɨɛ |
Ⱦɥɢɬɟɥɶɧɨɫɬɶ |
ɉɪɢɦɟɱɚɧɢɟ |
ɨɫɧɨɜɧɨɣ |
|
ɩɪɟɩɚɪɚɬɵ (Ʌɋ) |
ɞɨɡɚ |
|
ɞɨɡɚ |
ɜɜɟɞɟɧɢɹ |
ɬɟɪɚɩɢɢ |
|
ɜɨɡɛɭɞɢɬɟɥɶ |
|
|
|
|
|
|
|
|
|
|
(«ɉɚɥɢɧ») |
|
|
|
|
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
|
|
ɇɢɬɪɨɮɭɪɚɧɵ: |
|
|
|
|
|
|
|
|
ɇɢɬɪɨɮɭɪɚɧɬɨɢɧ («Ɏɭ- |
0,05–0,1 ɝ |
|
0,2–0,4 ɝ |
ɜɧɭɬɪɶ |
10–12 ɫɭɬ |
|
|
|
ɪɚɞɨɧɢɧ») |
|
|
|
|
|
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
|
Ɏɭɪɚɡɨɥɢɞɨɧ |
0,1 ɝ |
|
0,1 ɝ |
ɜɧɭɬɪɶ |
10–12 ɫɭɬ |
|
|
|
|
|
|
|
|
|
|
|
|
ɊȺɋɌɂɌȿɅɖɇɕȿ ɍɊɈȺɇɌɂɋȿɉɌɂɄɂ |
|
|
|
|
||
|
|
«Ʉɚɧɟɮɪɨɧ-ɇ» |
5 ɝ |
|
15 ɝ |
ɜɧɭɬɪɶ |
Ⱦɥɢɬɟɥɶɧɵɣ ɩɪɢ- |
|
|
|
ɢɥɢ |
|
|
|
|
ɟɦ ɩɪɟɩɚɪɚɬɨɜ |
|
|
|
Ɏɢɬɨɥɢɡɢɧ |
5 ɝ |
|
15 ɝ |
ɜɧɭɬɪɶ |
|
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
|
Ɉɬɜɚɪ ɦɨɱɟɝɨɧɧɵɯ ɬɪɚɜ |
100 ɦɥ |
|
250–300 |
ɜɧɭɬɪɶ |
|
|
|
|
|
|
|
ɦɥ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
ȾȿɁɂɇɌɈɄɋɂɄȺɐɂɈɇɇȺə |
ɌȿɊȺɉɂə |
|
|
|
|
ɂɧɮɭɡɢɨɧɧɚɹ ɬɟɪɚɩɢɹ |
|
|
Ⱦɟɤɫɬɪɨɡɚ 5% ɪ-ɪ (ɝɥɸ- |
400 ɦɥ |
|
400 ɦɥ |
ɜ/ɜ ɤɚɩɟɥɶɧɨ |
2–3 ɫɭɬ |
ɩɪɢ ɨɫɬɪɨɦ ɩɢɟɥɨ- |
|
|
ɤɨɡɚ) |
|
|
|
|
|
ɧɟɮɪɢɬɟ |
|
|
ɢɥɢ |
|
|
|
|
|
|
|
|
ɏɥɨɪɢɞ ɧɚɬɪɢɹ |
400 ɦɥ |
|
400 ɦɥ |
ɜ/ɜ ɤɚɩɟɥɶɧɨ |
2–3 ɫɭɬ |
|
|
|
0,9% ɪ-ɪ |
|
|
|
|
|
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
|
ɉɨɜɢɞɨɧ 8000+ɧɚɬɪɢɹ |
400 ɦɥ |
|
400 ɦɥ |
ɜ/ɜ ɤɚɩɟɥɶɧɨ |
2–3 ɫɭɬ |
|
|
|
ɯɥɨɪɢɞ + ɤɚɥɢɹ ɯɥɨɪɢɞ |
|
|
|
|
|
|
|
|
+ ɤɚɥɶɰɢɹ ɯɥɨɪɢɞ+ |
|
|
|
|
|
|
|
|
ɦɚɝɧɢɹ ɯɥɨɪɢɞ+ɧɚɬɪɢɹ |
|
|
|
|
|
|
|
|
ɝɢɞɪɨɤɚɪɛɨɧɚɬ («Ƚɟɦɨ- |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
145 ...заболеваний инфекционных терапии при применяемые ЛС,
Ɂɚɛɨɥɟɜɚɧɢɟ, |
|
Ʌɟɤɚɪɫɬɜɟɧɧɵɟ |
Ɋɚɡɨɜɚɹ |
ɋɭɬɨɱɧɚɹ |
ɋɩɨɫɨɛ |
Ⱦɥɢɬɟɥɶɧɨɫɬɶ |
ɉɪɢɦɟɱɚɧɢɟ |
ɨɫɧɨɜɧɨɣ |
|
ɩɪɟɩɚɪɚɬɵ (Ʌɋ) |
ɞɨɡɚ |
ɞɨɡɚ |
ɜɜɟɞɟɧɢɹ |
ɬɟɪɚɩɢɢ |
|
ɜɨɡɛɭɞɢɬɟɥɶ |
|
|
|
|
|
|
|
|
|
ɞɟɡ-ɇ») |
|
|
|
|
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
Ⱦɟɤɫɬɪɚɧ [ɫɪɟɞɧɹɹ ɦɨ- |
400 ɦɥ |
400 ɦɥ |
ɜ/ɜ ɤɚɩɟɥɶɧɨ |
2–3 ɫɭɬ |
|
|
|
ɥɟɤɭɥɹɪɧɚɹ ɦɚɫɫɚ |
|
|
|
|
|
|
|
30 000–40 000] («Ɋɟɨ- |
|
|
|
|
|
|
|
ɩɨɥɢɝɥɸɤɢɧ») ɪ-ɪ |
|
|
|
|
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
Ƚɢɞɪɨɤɫɢɷɬɢɥɤɪɚɯɦɚɥ |
250–500 ɦɥ |
500 ɦɥ |
ɜ/ɜ ɤɚɩɟɥɶɧɨ |
2–3 ɫɭɬ |
|
|
|
6–10% ɪ-ɪ («Ɋɟɮɨɪɬɚɧ |
|
|
|
|
|
|
|
ȽɗɄ») |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
ȾȿɋȿɇɋɂȻɂɅɂɁɂɊɍɘɓȺə |
ɌȿɊȺɉɂə |
|
|
|
ɉɪɢɦɟɧɹɟɬɫɹ ɨɞɧɨ- |
|
|
Ⱦɢɮɟɧɝɢɞɪɚɦɢɧ («Ⱦɢ- |
1 ɦɥ |
2–3 ɦɥ |
ɜ/ɦ |
5–7 ɫɭɬ |
ɜɪɟɦɟɧɧɨ ɫ ɚɧɬɢɛɚɤ- |
|
|
ɦɟɞɪɨɥ») 1% ɪ-ɪ ɢɥɢ |
|
|
|
|
ɬɟɪɢɚɥɶɧɵɦɢ ɢ ɩɪɨ- |
|
|
ɜɧɭɬɪɶ |
0,05 |
0,1 |
ɜɧɭɬɪɶ |
5–7 ɫɭɬ |
ɬɢɜɨɜɨɫɩɚɥɢɬɟɥɶɧɵɦɢ |
|
|
ɢɥɢ |
|
|
|
|
ɩɪɟɩɚɪɚɬɚɦɢ |
|
|
ɉɪɨɦɟɬɚɡɢɧ 2,5% ɪ-ɪ |
2 ɦɥ |
4 ɦɥ |
ɜ/ɦ |
5–7 ɫɭɬ |
|
|
|
(«Ⱦɢɩɪɚɡɢɧ», «ɉɢ- |
|
|
|
|
|
|
|
ɩɨɥɶɮɟɧ») ɢɥɢ ɜɧɭɬɪɶ |
0,025 ɝ |
0,05 ɝ |
ɜɧɭɬɪɶ |
5–7 ɫɭɬ |
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
ɏɥɨɪɨɩɢɪɚɦɢɧ («ɋɭɩ- |
2% ɪ-ɪ 1 ɦɥ |
2 ɦɥ |
ɜ/ɦ |
5–7 ɫɭɬ |
|
|
|
ɪɚɫɬɢɧ») |
|
|
|
|
|
|
|
ɢɥɢ ɜɧɭɬɪɶ |
0,025 ɝ |
0,05 ɝ |
ɜɧɭɬɪɶ |
5–7 ɫɭɬ |
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
Ɇɟɛɝɢɞɪɨɥɢɧ («Ⱦɢɚɡɨ- |
0,1 ɝ |
0,2–0,3 ɝ |
ɜɧɭɬɪɶ |
5–7 ɫɭɬ |
|
|
|
ɥɢɧ») |
|
|
|
|
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
|
|
|
|
|
|
146
6 Раздел
Ɂɚɛɨɥɟɜɚɧɢɟ, |
|
|
Ʌɟɤɚɪɫɬɜɟɧɧɵɟ |
Ɋɚɡɨɜɚɹ |
ɋɭɬɨɱɧɚɹ |
ɋɩɨɫɨɛ |
Ⱦɥɢɬɟɥɶɧɨɫɬɶ |
ɉɪɢɦɟɱɚɧɢɟ |
||
ɨɫɧɨɜɧɨɣ |
|
|
ɩɪɟɩɚɪɚɬɵ (Ʌɋ) |
ɞɨɡɚ |
ɞɨɡɚ |
ɜɜɟɞɟɧɢɹ |
ɬɟɪɚɩɢɢ |
|
||
ɜɨɡɛɭɞɢɬɟɥɶ |
|
|
|
|
|
|
|
|
|
|
|
|
|
Ʉɟɬɨɬɢɮɟɧ |
0,001 ɝ |
0,002 ɝ |
ɜɧɭɬɪɶ |
5–7 ɫɭɬ |
|
||
|
|
|
ɢɥɢ |
|
|
|
|
|
||
|
|
|
ɏɢɮɟɧɚɞɢɧ («Ɏɟɧɤɚ- |
0,025 ɝ |
0,05– |
ɜɧɭɬɪɶ |
5–7 ɫɭɬ |
|
||
|
|
|
ɪɨɥ») |
|
0,075 ɝ |
|
|
|
||
|
|
|
ɢɥɢ |
|
|
|
|
|
||
|
|
|
Ʌɨɪɚɬɚɞɢɧ («Ʉɥɚɪɢ- |
0,01 ɝ |
0,01 ɝ |
ɜɧɭɬɪɶ |
5–7 ɫɭɬ |
|
||
|
|
|
ɬɢɧ») |
|
|
|
|
|
||
|
|
|
|
|
|
|
|
|
|
|
|
|
ɋɉȺɁɆɈɅɂɌɂɄɂ |
|
|
|
|
|
|||
|
|
|
Ⱦɪɨɬɚɜɟɪɢɧɚ ɝɢɞɪɨɯɥɨ- |
2 ɦɥ |
4–6 ɦɥ |
ɜ/ɜ, ɜ/ɦ |
ɉɨ ɩɨɬɪɟɛɧɨɫɬɢ |
ɉɪɢ ɛɨɥɹɯ |
||
|
|
|
ɪɢɞ («ɇɨ-ɲɩɚ») |
|
|
|
|
|
||
|
|
|
ɢɥɢ |
|
|
|
|
|
||
|
|
|
Ɇɟɬɚɦɢɡɨɥ ɧɚɬɪɢɹ |
5 ɦɥ |
5–10 ɦɥ |
ɜ/ɜ, ɜ/ɦ |
|
|
||
|
|
|
(«Ȼɚɪɚɥɝɢɧ Ɇ») |
|
|
|
|
|
||
|
|
|
|
|
|
|
|
|
|
|
|
|
ɋȺɅɍɊȿɌɂɄɂ |
|
|
|
|
ɋ ɨɫɬɨɪɨɠɧɨɫɬɶɸ ɩɪɢ |
|||
|
|
|
Ɏɭɪɨɫɟɦɢɞ («Ʌɚɡɢɤɫ») |
1–2 ɦɥ |
2 ɦɥ |
ɜ/ɜ |
2–3 ɫɭɬ |
ɦɨɱɟɤɚɦɟɧɧɨɣ ɛɨɥɟɡ- |
||
|
|
|
1% ɪ-ɪ |
|
|
|
|
ɧɢ |
||
|
|
|
ɢɥɢ |
|
|
|
|
|
||
|
|
|
Ɏɭɪɨɫɟɦɢɞ («Ʌɚɡɢɤɫ») |
0,04 ɝ |
0,04–0,08 ɝ |
ɜɧɭɬɪɶ |
2–3 ɫɭɬ |
|
||
|
|
|
|
|
|
|
|
|
|
|
|
|
ɗɎɎȿɊȿɇɌɇɕȿ ɆȿɌɈȾɕ |
|
|
|
|
|
|||
|
I. |
|
ɉɥɚɡɦɚɮɟɪɟɡ. Ɋ-ɪɵ ɞɥɹ ɟɝɨ ɩɪɨɜɟɞɟɧɢɹ: |
|
|
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ȼɟɥɤɨɜɵɟ |
|
|
|
|
|
|
|
|
|
|
Ⱥɥɶɛɭɦɢɧ 10% ɪ-ɪ |
100 ɦɥ |
100–200 |
ɜ/ɜ ɤɚɩɟɥɶɧɨ |
2–3 ɫɭɬ |
|
||
|
|
|
|
|
|
|
ɦɥ |
|
|
|
|
|
|
Ʉɨɥɥɨɢɞɵ: |
|
|
|
|
|
|
|
|
|
|
Ƚɢɞɪɨɤɫɢɷɬɢɥɤɪɚɯɦɚɥ |
250–500 ɦɥ |
500 ɦɥ |
ɜ/ɜ ɤɚɩɟɥɶɧɨ |
2–3 ɫɭɬ |
|
||
|
|
|
6–10% ɪ-ɪ («Ɋɟɮɨɪɬɚɧ |
|
|
|
|
|
||
|
|
|
|
|
|
|
|
|
|
|
147 ...заболеваний инфекционных терапии при применяемые ЛС,
Ɂɚɛɨɥɟɜɚɧɢɟ, |
|
|
Ʌɟɤɚɪɫɬɜɟɧɧɵɟ |
Ɋɚɡɨɜɚɹ |
ɋɭɬɨɱɧɚɹ |
ɋɩɨɫɨɛ |
Ⱦɥɢɬɟɥɶɧɨɫɬɶ |
ɉɪɢɦɟɱɚɧɢɟ |
||
ɨɫɧɨɜɧɨɣ |
|
|
ɩɪɟɩɚɪɚɬɵ (Ʌɋ) |
ɞɨɡɚ |
ɞɨɡɚ |
ɜɜɟɞɟɧɢɹ |
ɬɟɪɚɩɢɢ |
|
||
ɜɨɡɛɭɞɢɬɟɥɶ |
|
|
|
|
|
|
|
|
|
|
|
|
|
ȽɗɄ») |
|
|
|
|
|
||
|
|
|
ɢɥɢ |
|
|
|
|
|
||
|
|
|
Ⱦɟɤɫɬɪɚɧ [ɫɪɟɞɧɹɹ ɦɨ- |
400 ɦɥ |
400 ɦɥ |
ɜ/ɜ ɤɚɩɟɥɶɧɨ |
2–3 ɫɭɬ |
|
||
|
|
|
ɥɟɤɭɥɹɪɧɚɹ ɦɚɫɫɚ |
|
|
|
|
|
||
|
|
|
30 000–40 000] («Ɋɟɨ- |
|
|
|
|
|
||
|
|
|
ɩɨɥɢɝɥɸɤɢɧ») ɪ-ɪ |
|
|
|
|
|
||
|
|
|
ɢɥɢ |
|
|
|
|
|
||
|
|
|
ɉɨɜɢɞɨɧ 8000+ɧɚɬɪɢɹ |
200–400 ɦɥ |
200–400 |
ɜ/ɜ ɤɚɩɟɥɶɧɨ |
2–3 ɫɭɬ |
|
||
|
|
|
ɯɥɨɪɢɞ |
|
ɦɥ |
|
|
|
||
|
|
|
+ ɤɚɥɢɹ ɯɥɨɪɢɞ + ɤɚɥɶ- |
|
|
|
|
|
||
|
|
|
ɰɢɹ ɯɥɨɪɢɞ+ ɦɚɝɧɢɹ |
|
|
|
|
|
||
|
|
|
ɯɥɨɪɢɞ+ɧɚɬɪɢɹ ɝɢɞɪɨ- |
|
|
|
|
|
||
|
|
|
ɤɚɪɛɨɧɚɬ |
|
|
|
|
|
||
|
|
|
(«Ƚɟɦɨɞɟɡ-ɇ») |
|
|
|
|
|
||
|
|
|
ɢɥɢ |
|
|
|
|
|
||
|
|
|
Ⱦɟɤɫɬɪɚɧ [ɫɪɟɞɧɹɹ ɦɨ- |
400 ɦɥ |
400 ɦɥ |
ɜ/ɜ ɤɚɩɟɥɶɧɨ |
2–3 ɫɭɬ |
|
||
|
|
|
ɥɟɤɭɥɹɪɧɚɹ ɦɚɫɫɚ |
|
|
|
|
|
||
|
|
|
50 000–70 000] («ɉɨɥɢ- |
|
|
|
|
|
||
|
|
|
ɝɥɸɤɢɧ») ɪ-ɪ |
|
|
|
|
|
||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ʉɪɢɫɬɚɥɥɨɢɞɵ: |
|
|
|
|
|
|
|
|
|
|
ɇɚɬɪɢɹ ɯɥɨɪɢɞ |
400 ɦɥ |
400 ɦɥ |
ɜ/ɜ |
2–3 ɫɭɬ |
|
||
|
|
|
0,9% ɪ-ɪ |
|
|
|
|
|
||
|
|
|
Ⱥɧɬɢɤɨɚɝɭɥɹɧɬɵ: |
|
|
|
|
|
|
|
|
|
|
Ƚɟɩɚɪɢɧ ɧɚɬɪɢɹ |
5000–7500 ȿȾ |
5000–7500 |
ɜ/ɜ |
3–5 ɫɭɬ |
|
||
|
|
|
|
|
|
|
ȿȾ |
|
|
|
|
|
|
|
|
|
|
|
|||
|
II. |
Ɉɡɨɧɨɬɟɪɚɩɢɹ |
|
|
|
|
|
|||
148
6 Раздел
Ɂɚɛɨɥɟɜɚɧɢɟ, |
|
|
Ʌɟɤɚɪɫɬɜɟɧɧɵɟ |
Ɋɚɡɨɜɚɹ |
ɋɭɬɨɱɧɚɹ |
ɋɩɨɫɨɛ |
Ⱦɥɢɬɟɥɶɧɨɫɬɶ |
ɉɪɢɦɟɱɚɧɢɟ |
|
ɨɫɧɨɜɧɨɣ |
|
|
ɩɪɟɩɚɪɚɬɵ (Ʌɋ) |
ɞɨɡɚ |
ɞɨɡɚ |
ɜɜɟɞɟɧɢɹ |
ɬɟɪɚɩɢɢ |
|
|
ɜɨɡɛɭɞɢɬɟɥɶ |
|
|
|
|
|
|
|
|
|
|
|
|
Ʉɪɢɫɬɚɥɥɨɢɞɵ: |
|
|
|
|
|
|
|
|
|
ɇɚɬɪɢɹ ɯɥɨɪɢɞ |
400 ɦɥ |
400 ɦɥ |
ɜ/ɜ |
2–3 ɪɚɡɚ |
|
|
|
|
|
0,9% ɪ-ɪ, |
|
|
|
|
|
|
|
|
|
ɨɛɨɝɚɳɟɧɧɵɣ ɨɡɨɧɨɦ |
|
|
|
|
|
|
|
|
|
2,5–4,0% |
|
|
|
|
|
|
|
ɉɪɢ ɨɬɫɭɬɫɬɜɢɢ ɷɮɮɟɤɬɚ ɨɬ |
ɩɪɨɜɨɞɢɦɨɣ ɤɨɦɩɥɟɤɫɧɨɣ ɬɟɪɚɩɢɢ ɨɫɬɪɨɝɨ ɩɢɟɥɨɧɟɮɪɢɬɚ ɜ ɬɟɱɟɧɢɟ 2–3 ɫɭɬ (ɩɪɨɞɨɥ- |
|||||||
|
ɠɚɸɳɢɟɫɹ ɨɡɧɨɛɵ, ɝɟɤɬɢɱɟɫɤɚɹ ɥɢɯɨɪɚɞɤɚ, ɜɵɪɚɠɟɧɧɚɹ ɢɧɬɨɤɫɢɤɚɰɢɹ, ɜɨɫɩɚɥɢɬɟɥɶɧɵɟ ɢɡɦɟɧɟɧɢɹ ɩɨɤɚɡɚɬɟɥɟɣ ɤɪɨ- |
||||||||
|
ɜɢ ɢ ɦɨɱɢ) ɩɪɨɢɡɜɨɞɹɬ ɨɩɟɪɚɰɢɸ: ɞɟɤɚɩɫɭɥɹɰɢɸ ɩɨɱɤɢ, ɧɟɮɪɨɫɬɨɦɢɸ, ɜɫɤɪɵɬɢɟ ɝɧɨɣɧɵɯ ɨɱɚɝɨɜ, ɞɪɟɧɢɪɨɜɚɧɢɟ ɨɤɨ- |
||||||||
|
ɥɨɩɨɱɟɱɧɨɝɨ ɩɪɨɫɬɪɚɧɫɬɜɚ; ɫɦɟɧɭ ɚɧɬɢɛɚɤɬɟɪɢɚɥɶɧɵɯ ɩɪɟɩɚɪɚɬɨɜ ɢ ɩɪɨɞɨɥɠɚɸɬ ɤɨɦɩɥɟɤɫɧɭɸ ɬɟɪɚɩɢɸ |
||||||||
|
|
|
|||||||
Ɉ23.4 Ȼɟɫɫɢɦ- |
ȺɇɌɂȻȺɄɌȿɊɂȺɅɖɇȺə ɂ ɉɊɈɌɂȼɈȼɈɋɉȺɅɂɌȿɅɖɇȺə ɌȿɊȺɉɂə |
|
|||||||
ɩɬɨɦɧɚɹ ɛɚɤɬɟ- |
I ɌɊɂɆȿɋɌɊ |
|
|
|
|
|
|||
ɪɢɭɪɢɹ ɭ ɛɟɪɟ- |
|
|
|
|
|
|
|
|
|
|
|
Ⱥɦɩɢɰɢɥɥɢɧ |
0,5 ɝ |
1,5–2 ɝ |
ɜɧɭɬɪɶ |
7–10 ɫɭɬ |
|
||
ɦɟɧɧɵɯ |
|
|
ɢɥɢ |
|
|
|
|
|
|
E. сoli, Proteus |
|
|
Ⱥɦɨɤɫɢɰɢɥɥɢɧ |
0,25–0,5 ɝ |
2–3 ɝ |
ɜɧɭɬɪɶ |
7–10 ɫɭɬ |
|
|
spp., |
|
|
ɢɥɢ |
|
|
|
|
|
|
Klebsiella spp., |
|
|
Ⱥɦɩɢɰɢɥ- |
0,375–0,75 ɝ |
0,75–1,5 ɝ |
ɜɧɭɬɪɶ |
7–10 ɫɭɬ |
|
|
Enterobacter |
|
|
ɥɢɧ+ɫɭɥɶɛɚɤɬɚɦ («ɍɧɚ- |
|
|
|
|
|
|
spp., |
|
|
ɡɢɧ», «ɋɭɥɚɰɢɥɥɢɧ») |
|
|
|
|
|
|
Enterococcus |
|
|
ɢɥɢ |
|
|
|
|
|
|
spp. ɢ ɞɪ. |
|
|
Ⱥɦɨɤɫɢɰɢɥ- |
0,375–0,625 ɝ |
1,25– |
ɜɧɭɬɪɶ |
7–10 ɫɭɬ |
|
|
|
|
|
ɥɢɧ+ɤɥɚɜɭɥɚɧɨɜɚɹ ɤɢ- |
|
1,875 ɝ |
|
|
|
|
|
|
|
ɫɥɨɬɚ («Ⱥɭɝɦɟɧɬɢɧ», |
|
|
|
|
|
|
|
|
«Ⱥɦɨɤɫɢɤɥɚɜ») |
|
|
|
|
|
||
|
II–III ɌɊɂɆȿɋɌɊ |
|
|
|
|
|
|||
|
|
|
Ⱥɦɩɢɰɢɥɥɢɧ |
0,5 ɝ |
1,5–2 ɝ |
ɜɧɭɬɪɶ |
7–10 ɫɭɬ |
|
|
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
149 ...заболеваний инфекционных терапии при применяемые ЛС,
Ɂɚɛɨɥɟɜɚɧɢɟ, |
|
Ʌɟɤɚɪɫɬɜɟɧɧɵɟ |
Ɋɚɡɨɜɚɹ |
ɋɭɬɨɱɧɚɹ |
ɋɩɨɫɨɛ |
Ⱦɥɢɬɟɥɶɧɨɫɬɶ |
ɉɪɢɦɟɱɚɧɢɟ |
|
150 |
|
|
|
|||||||
ɨɫɧɨɜɧɨɣ |
|
ɩɪɟɩɚɪɚɬɵ (Ʌɋ) |
ɞɨɡɚ |
ɞɨɡɚ |
ɜɜɟɞɟɧɢɹ |
ɬɟɪɚɩɢɢ |
|
|
|
ɜɨɡɛɭɞɢɬɟɥɶ |
|
|
|
|
|
|
|
|
|
|
|
Ⱥɦɨɤɫɢɰɢɥɥɢɧ |
0,25–0,5 ɝ |
2–3 ɝ |
ɜɧɭɬɪɶ |
5 ɫɭɬ |
|
|
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
|
|
Ⱥɦɩɢɰɢɥ- |
0,375–0,75 ɝ |
0,75–1,5 ɝ |
ɜɧɭɬɪɶ |
5 ɫɭɬ |
|
|
|
|
|
ɥɢɧ+ɫɭɥɶɛɚɤɬɚɦ («ɍɧɚ- |
|
|
|
|
|
|
|
|
|
ɡɢɧ», «ɋɭɥɚɰɢɥɥɢɧ») |
|
|
|
|
|
|
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
|
|
Ⱥɦɨɤɫɢɰɢɥ- |
0,375–0,625 ɝ |
1,25– |
ɜɧɭɬɪɶ |
5 ɫɭɬ |
|
|
|
|
|
ɥɢɧ+ɤɥɚɜɭɥɚɧɨɜɚɹ ɤɢ- |
|
1,875 ɝ |
|
|
|
|
|
|
|
ɫɥɨɬɚ («Ⱥɭɝɦɟɧɬɢɧ», |
|
|
|
|
|
|
|
|
|
«Ⱥɦɨɤɫɢɤɥɚɜ») |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
|
|
|
ɐɟɮɭɪɨɤɫɢɦ («Ⱥɤɫɟ- |
0,25 ɝ |
0,5–0,75 ɝ |
ɜɧɭɬɪɶ |
7–10 ɫɭɬ |
|
|
|
|
|
ɬɢɧ», «Ɂɢɧɧɚɬ») |
|
|
|
|
|
|
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
|
|
ɇɢɬɪɨɮɭɪɚɧɬɨɢɧ («Ɏɭ- |
0,05–0,1 ɝ |
0,2–0,4 ɝ |
ɜɧɭɬɪɶ |
10–14 ɫɭɬ |
|
|
|
|
|
ɪɚɞɨɧɢɧ») |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ɉ23.1 ɂɧɮɟɤɰɢɹ |
|
ȺɇɌɂȻȺɄɌȿɊɂȺɅɖɇȺə |
ɂ ɉɊɈɌɂȼɈȼɈɋɉȺɅɂɌȿɅɖɇȺə ɌȿɊȺɉɂə |
|
|
|
|||
ɦɨɱɟɜɨɝɨ ɩɭɡɵ- |
|
|
|
|
|
|
|
|
|
ɪɹ ɩɪɢ ɛɟɪɟɦɟɧ- |
I ɌɊɂɆȿɋɌɊ |
|
|
|
|
|
|
|
|
ɧɨɫɬɢ. |
|
|
|
|
|
|
|
|
|
|
Ⱥɦɩɢɰɢɥɥɢɧ |
0,5 ɝ |
2 ɝ |
ɜɧɭɬɪɶ |
5–7 ɫɭɬ |
|
|
|
|
E. сoli, Proteus |
|
ɢɥɢ |
|
|
|
|
|
|
|
spp., |
|
Ⱥɦɨɤɫɢɰɢɥɥɢɧ |
0,5 ɝ |
2 ɝ |
ɜɧɭɬɪɶ |
5–7 ɫɭɬ |
|
|
|
Klebsiella spp., |
|
ɢɥɢ |
|
|
|
|
|
|
Раздел |
Enterobacter |
|
Ⱥɦɨɤɫɢɰɢɥ- |
0,375 ɝ |
1,125 ɝ |
ɜɧɭɬɪɶ |
5–7 ɫɭɬ |
|
|
|
spp., |
|
ɥɢɧ+ɤɥɚɜɭɥɚɧɨɜɚɹ ɤɢ- |
|
|
|
|
|
|
|
Enterococcus |
|
ɫɥɨɬɚ («Ⱥɭɝɦɟɧɬɢɧ», |
|
|
|
|
|
|
6 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ɂɚɛɨɥɟɜɚɧɢɟ, |
|
Ʌɟɤɚɪɫɬɜɟɧɧɵɟ |
Ɋɚɡɨɜɚɹ |
ɋɭɬɨɱɧɚɹ |
ɋɩɨɫɨɛ |
Ⱦɥɢɬɟɥɶɧɨɫɬɶ |
ɉɪɢɦɟɱɚɧɢɟ |
ɨɫɧɨɜɧɨɣ |
|
ɩɪɟɩɚɪɚɬɵ (Ʌɋ) |
ɞɨɡɚ |
ɞɨɡɚ |
ɜɜɟɞɟɧɢɹ |
ɬɟɪɚɩɢɢ |
|
ɜɨɡɛɭɞɢɬɟɥɶ |
|
|
|
|
|
|
|
spp. |
|
«Ⱥɦɨɤɫɢɤɥɚɜ») |
|
|
|
|
|
ɢ ɞɪ. |
|
|
|
|
|
|
|
|
II |
ɌɊɂɆȿɋɌɊ |
|
|
|
|
|
|
|
Ⱥɦɩɢɰɢɥɥɢɧ |
0,5 ɝ |
2 ɝ |
ɜɧɭɬɪɶ |
5–7 ɫɭɬ |
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
Ⱥɦɨɤɫɢɰɢɥɥɢɧ |
0,5 ɝ |
2 ɝ |
ɜɧɭɬɪɶ |
5–7 ɫɭɬ |
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
Ⱥɦɨɤɫɢɰɢɥ- |
0,375 ɝ |
1,125 ɝ |
ɜɧɭɬɪɶ |
5–7 ɫɭɬ |
|
|
|
ɥɢɧ+ɤɥɚɜɭɥɚɧɨɜɚɹ ɤɢ- |
|
|
|
|
|
|
|
ɫɥɨɬɚ («Ⱥɭɝɦɟɧɬɢɧ», |
|
|
|
|
|
|
|
«Ⱥɦɨɤɫɢɤɥɚɜ») |
|
|
|
|
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
ɐɟɮɭɪɨɤɫɢɦ («Ⱥɤɫɟ- |
0,25 ɝ |
0,5–0,75 ɝ |
ɜɧɭɬɪɶ |
5–7 ɫɭɬ |
|
|
|
ɬɢɧ», «Ɂɢɧɧɚɬ») |
|
|
|
|
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
ɇɢɬɪɨɮɭɪɚɧɬɨɢɧ («Ɏɭ- |
0,05–0,1 ɝ |
0,2–0,4 ɝ |
ɜɧɭɬɪɶ |
5–7 ɫɭɬ |
|
|
|
ɪɚɞɨɧɢɧ») |
|
|
|
|
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
Ɏɭɪɚɡɨɥɢɞɨɧ |
0,1 ɝ |
0,4 ɝ |
ɜɧɭɬɪɶ |
5–7 ɫɭɬ |
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
Ɏɨɫɮɨɦɢɰɢɧ («Ɇɨɧɭ- |
0,3 ɝ |
0,3 ɝ |
ɜɧɭɬɪɶ |
1–2 ɫɭɬ |
|
|
|
ɪɚɥ») |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ⱥɦɩɢɰɢɥɥɢɧ |
0,5 ɝ |
1,5–2 ɝ |
ɜɧɭɬɪɶ |
5–7 ɫɭɬ |
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
Ⱥɦɨɤɫɢɰɢɥɥɢɧ |
0,25–0,5 ɝ |
0,75–1,5 ɝ |
ɜɧɭɬɪɶ |
5–7 ɫɭɬ |
|
|
|
ɢɥɢ |
|
|
|
|
|
151 ...заболеваний инфекционных терапии при применяемые ЛС,